Oxidative Medicine and Cellular Longevity · مجلد 2020 · 1-12
Exposure to lead (Pb) causes multiorgan dysfunction including reproductive impairments. Here, we examined the protective effects of coenzyme Q10 (CoQ10) administration on testicular injury induced by lead acetate (PbAc) exposure in rats. This study employed four experimental groups ( n=7 ) that underwent seven days of treatment as follows: control group intraperitoneally (i.p.) treated with 0.1 ml of 0.9% NaCl containing 1% Tween 80 ( v:v ), CoQ10 group that was i.p. injected with 10 mg/kg CoQ10, PbAc group that was i.p. treated with PbAc (20 mg/kg), and PbAc+CoQ10 group that was i.p. injected with CoQ10 2 h after PbAc. PbAc injection resulted in increasing residual Pb levels in the testis and reducing testosterone, luteinizing hormone, and follicle-stimulating hormone levels. Additionally, PbAc exposure resulted in significant oxidative damage to the tissues on the testes. PbAc raised the levels of prooxidants (malondialdehyde and nitric oxide) and reduced the amount of endogenous antioxidative proteins (glutathione and its derivative enzymes, catalase, and superoxide dismutase) available in the cell. Moreover, PbAc induced the inflammatory response as evidenced by the upregulation of inflammatory mediators (tumor necrosis factor-alpha and interleukin-1 beta). Further, PbAc treatment induced apoptosis in the testicular cells, as indicated by an increase in Bax and caspase 3 expression, and reduced Bcl2 expression. CoQ10 supplementation improved testicular function by inhibiting Pb accumulation, oxidative stress, inflammation, cell death, and histopathological changes following PbAc exposure. Our findings suggest that CoQ10 can act as a natural therapeutic agent to protect against the reproductive impairments associated with PbAc exposure.
Human & Experimental Toxicology · مجلد 40 (4) · 707-721
Despite wide application of sodium nitrite (SN) as food additive, it exhibits considerable side effects on various body organs at high dose or chronic exposure. The aim of this study was to test whether Glycyrrhizic acid (GA) could ameliorate SN-induced toxicity in lung and submandibular salivary gland (SMG). A sample size of 30 adult male albino rats was randomly allocated into 3 groups. Group 1 served as control group. Rats were treated orally with 80 mg/kg of SN in group 2 or SN preceded by (15 mg/kg) GA in group 3. Lung & SMG tissues were used for oxidative stress assessment, examination of histopathological changes, fibrosis (MTC, TGF-β and α-SMA) and inflammation (TNF-α, IL-1β and CD-68). Concurrent administration of GA ameliorated pulmonary and salivary SN-induced toxicity via restoring the antioxidant defense mechanisms with reduction of MDA levels. GA reduced the key regulators of fibrosis TGF-β and α-SMA and collagen deposition. In addition to reduction of inflammatory cytokine (TNF-α, IL-1β) and macrophages recruitments, GA amended both pulmonary and salivary morphological changes. The present study proposed GA as a promising natural herb with antioxidant, anti-inflammatory and antifibrotic effects against pulmonary and salivary SN-induced toxicity.
BACKGROUND AND PURPOSE: Rabeprazole, a proton pump inhibitor (PPIs) is much endorsed to patients with increased gastric acidity. PPIs were accused to have osteoporotic effects on patients who chronically use them. The point of the current investigation was to decide the impact of rabeprazole on osteoporosis and to explore the modulatory effects of dietary calcium or alendronate on this side effect. METHODS: 80 female mice were alienated into four groups maintained for 18 weeks: [1] Vehicle group: given distilled water in 12 ml/kg, P.O. [2] Rabeprazole control group: given rabeprazole in a dose equals 10 mg/kg every 48 h, P.O. [3] Rabeprazole + calcium: given rabeprazole (10 mg/kg every 48 h) along with calcium supplement. [4] Rabeprazole + alendronate: given rabeprazole (10 mg/kg every 48 h) and alendronate (1 mg/kg per week, i.p.). Serum calcium, phosphorus and parathyroid hormone were measured. Both femurs were kept in paraformaldehyde, and then the right one was used for X-ray examination with analysis by Digora software and the left one for histopathological examination (H&E) and immunohistochemical stains for osteopontin and tartrate resistant acid phosphatase (TRAP). RESULTS: Calcium supplementation or administration of alendronate along with rabeprazole significantly restored the mean bone density as shown by X-ray analysis. Femurs from mice received rabeprazole showed widely separated, thin-walled bone trabeculae and increased number of osteoclasts. Calcium or alendronate with rabeprazole showed thick bone trabeculae without full recovery from rabeprazole induced damage. Adding calcium supplementation to rabeprazole did not affect the histological abnormalities related to osteoclasts meanwhile alendronate produced inactivation of osteoclasts. Both calcium and alendronate decreased the rabeprazole-induced increment in the femur osteopontin level. CONCLUSION: Calcium or alendronate can be recommended for female patients on PPI therapy who are at risk of osteopenia.
The Medical Journal of Cairo University/The Medical Journal of Cairo University · مجلد 88 (3) · 775-785
Background: Obesity is a major health problem which may lead to infertility, vitamin D has anti-inflammatory, anti-oxidant, anti-apoptotic properties and metabolic activities Nano emulsions are very effective delivery system for medicines and nutrients. Nano vitamin D has a greater water solubility and stability compared to the conventional vitamin D. Aim of Study: The study aims to evaluate the potential protective effects of vitamin D3nanoemulsionintervention against some altered testicular, metabolic and hormonal changes in high-fat diet (HFD)-induced obese rats. Material and Methods: 32 adult male albino rats were equally and randomly divided into four groups: Group I (control group on standard diet), group II (untreated HFD), group III (HFD + conventional vitamin D) and group IV (HFD + Nano vitamin D3). Vitamin D3 administration was begun along with the start of introduction of the high fat diet. After eight weeks, body weight (BW) was measured and body mass index (BMI) was calculated then rats were euthanized. Serum testosterone, insulin and glucose levels were measured; home-ostasis model assessment of insulin resistance (HOMA-IR) was calculated. In addition, testicular levels of malondialdhyde (MDA), superoxide dismutase (SOD), reduced glutathione (GSH), TNF-a and IL-6 were measured. The changes in the histopathological aspects of the testis were examined. The testicular weight, testicular coefficient, epidydimal sperm count and motility all were investigated. Results: Nano vitamin D3 treatment showed significant reductions in BMI, fasting serum glucose, insulin resistance, total cholesterol, LDL-c, with significant elevations in serum HDL-c, final testicular weight, testicular coefficient, epidy-dimal sperm count, sperm motility, and serum testosterone. Moreover, Nano vitamin D3 significantly increased the tes-ticular SOD and GSH with significant decline in the lipid peroxidation contributed to MDA, testicular TNF-a and IL-6 content. Improvement of the metabolic and biochemical measurements induced by Nano vitamin D3 is linked toim-provement of testicular histology in obese rats. Interestingly, Nano vitamin D3 has more significant protective effects against HFD-induced testicular dysfunction compared to the conventional vitamin D3.Conclusions: Nano vitamin D3 has a potential protective role in improving the adverse effects of HFD induced obesity on testicular functions, withmore prominent protective effects than conventional vitamin D3.
Journal of Family Medicine and Primary Care · مجلد 9 (6) · 2720-2720
Background: Hearing loss is a common disability affecting nearly 360 million people in the world and 75% of cases live in developing countries. Many children are vulnerable to diseases causing hearing loss that often go untreated. The aim of this study is to identify the possible etiological factors and clinical presentations of children who presented with hearing loss at the Khartoum Teaching Hospital. Materials and Methods: a descriptive, cross-sectional hospital-based study. A total of 100 (response rate of 94%) children aged 5–15 who presented with hearing loss at Khartoum Teaching Hospital were included in this study. A detailed structured, pretested, and pre-coded questionnaire was used. After data collection, hearing examination was performed by an E.N.T specialist, then audiometry performed to diagnose hearing loss and for classification of the hearing loss type. Discriptive Statisistics frequencies and cross-tabulation were done. A Chi-square test was used for proportions. A P value of less than 0.05 considered significant. Results: Out of 100 patients, 68 patients (68%) belonged to the 5–10 years age group. The mean age was 8.5 years. The male to female ratio was 1.00–1.13. Conductive hearing loss was found in 66% of the studied group, sensory-neural hearing loss in 23% and the mixed type in 11%. Regarding the etiology, otitis media was found in 41 of patients (41%), congenital hearing loss in 22% (22 patients), traumatic hearing loss in 4%, sickle cell anemia in 2%, mumps in 14%, diabetes mellitus in 3%, and measles in 8% of the patients. In conclusion, a number of preventable causes were shown to contribute significantly to the etiology of hearing loss. Conclusion: The commonest factors associated with hearing loss among participants were otitis media and hereditary causes, respectively. Further community-based studies of hearing-impaired children are necessary for planning effective preventive and curative programs.
childhood hearing lossconductive hearing losssensorineural hearing lossotitis media